Product Code: 2492
Vascular Graft Market is anticipated to register notable growth through 2032, owing to the increasing cases of chronic kidney diseases in developing countries. According to credible reports, chronic kidney disease impacts more than 10% (approximately over 800 million individuals) of the general population worldwide.
In addition, constant innovations in the vascular grafts will further support market growth. Citing an instance, researchers from the University of Waterloo, in 2022, devised a method of modifying synthetic vascular grafts from seaweed. The seaweed material, fucoidan, is anticipated to offer better bypass surgery outcomes.
Overall, the vascular graft industry is segmented in terms of raw material, application, end-user, and region.
Considering the raw material, the polyester graft market is anticipated to garner potential gains by 2032 end. The increasing adoption of polyester grafts across healthcare facilities would support the segment growth. Besides, high patency, longer lifespan, and easy accessibility are among the key benefits offered by polyester grafts, which will further increase its adoption in the foreseeable future.
Based on application, the hemodialysis access segment is anticipated to depict over 7% CAGR through 2032. The segmental growth can be credited to the increasing incidences of ESRD (end-stage renal disease) and the rising burden of CKD (chronic kidney disease). One of the prominently used vascular grafts for hemodialysis is an arteriovenous (AV) graft. Some of the advantages offered by these include solution for weak or small veins and ability to be used within 2-4 weeks after placement. Moreover, the AV graft surgery is done on an outpatient basis, enabling easy and faster recovery period. In addition, the rising adoption of minimally invasive procedures is further anticipated to drive the demand for hemodialysis access.
By end-use, the others segment accounted for USD 337.5 million revenue share in 2022. The others segment includes academic hospitals and research institutes. Increasing R&D and investment in offering the best treatments across these end-user organizations will significantly impact segmental expansion in the coming years.
Regionally, the North America vascular graft industry will grow considerably between 2023-2032. The regional market growth is anticipated to come from constantly increasing cases of cardiac disorders. As per CDC estimates, one person succumbs to death in every 34 seconds in the United States from CVDs. In addition, sedentary lifestyles, unhealthy eating habits, and alcohol abuse will play a key role in raising the number of vascular disease cases. The increasing adoption of novel and innovative vascular grafts for treating aortic aneurysms and the vascular bypass will further positively influence the overall regional expansion.
Table of Contents
Chapter 1 Methodology
- 1.1 Methodology
- 1.2 Market scope and definition
- 1.3 Base estimates and calculations
- 1.4 Forecast calculations
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Vascular graft market industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Raw material trends
- 2.1.3 Application trends
- 2.1.4 End-use
- 2.1.5 Regional trends
Chapter 3 Vascular Graft Market Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Vendor matrix
- 3.1.2 Distribution channel analysis
- 3.2 Raw material analysis
- 3.3 Pricing analysis 2018 - 2032
- 3.4 Cost structure analysis
- 3.5 Industry impact forces
- 3.5.1 Growth drivers
- 3.5.1.1 Increasing number chronic diseases worldwide
- 3.5.1.2 Growing number of end-stage renal disorders in developing economies
- 3.5.1.3 Technological advancements in developed countries
- 3.5.1.4 Growing geriatric population worldwide
- 3.5.2 Industry pitfalls & challenges
- 3.5.2.1 Lack of skilled personnel in developing countries
- 3.5.2.2 Vascular graft infections
- 3.6 Growth potential analysis
- 3.6.1 By raw material
- 3.6.2 By application
- 3.6.3 By end-use
- 3.7 COVID-19 impact analysis
- 3.8 Technology landscape
- 3.9 Regulatory scenario
- 3.10 Porter's analysis
- 3.10.1 Industry rivalry
- 3.10.2 Buyer power
- 3.10.3 Supplier power
- 3.10.4 Threat of substitute
- 3.10.5 Threat of new entrants
- 3.11 PESTEL analysis
- 3.11.1 Political
- 3.11.2 Economical
- 3.11.3 Social
- 3.11.4 Technological
- 3.11.5 Environmental
- 3.11.6 Legal
Chapter 4 Competitive Landscape, 2022
- 4.1 Introduction
- 4.2 Company market share, 2022
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategic outlook matrix
Chapter 5 Vascular Graft Market, By Raw Material
- 5.1 Key segment trends
- 5.2 Polyester grafts
- 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3 EPTFE Grafts
- 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4 Polyurethane grafts
- 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5 Biosynthetic grafts
- 5.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Vascular Graft Market, By Application
- 6.1 Key segment trends
- 6.2 Endovascular aneurysm repair
- 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.2.2 Abdominal aortic aneurysm repair
- 6.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.2.3 Thoracic aortic aneurysm repair
- 6.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3 Peripheral vascular repair
- 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.4 Hemodialysis access
- 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Vascular Graft Market, By End-use
- 7.1 Key segment trends
- 7.2 Hospitals
- 7.2.1 Market size, 2018 - 2032 (USD Million)
- 7.3 Ambulatory surgical centers
- 7.3.1 Market size, 2018 - 2032 (USD Million)
- 7.4 Others
- 7.4.1 Market size, 2018 - 2032 (USD Million)
Chapter 8 Vascular Graft Market, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.2.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.2.2 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.2.3 Market size, by application, 2018 - 2032 (USD Million)
- 8.2.3.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.2.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.2.5 U.S.
- 8.2.5.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.2.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.2.5.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.2.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.2.6 Canada
- 8.2.6.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.2.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.2.6.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.2.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3 Europe
- 8.3.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.3.2 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.3.3 Market size, by application, 2018 - 2032 (USD Million)
- 8.3.3.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.3.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.5 Germany
- 8.3.5.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.3.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.3.5.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.3.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.6 UK
- 8.3.6.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.3.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.3.6.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.3.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.7 France
- 8.3.7.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.3.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.3.7.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.3.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.8 Spain
- 8.3.8.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.3.8.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.3.8.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.3.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.9 Italy
- 8.3.9.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.3.9.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.3.9.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.3.9.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.4.2 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.4.3 Market size, by application, 2018 - 2032 (USD Million)
- 8.4.3.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.4.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.5 Japan
- 8.4.5.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.4.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.4.5.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.4.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.6 China
- 8.4.6.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.4.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.4.6.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.4.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.7 India
- 8.4.7.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.4.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.4.7.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.4.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.8 Australia
- 8.4.8.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.4.8.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.4.8.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.4.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.5 Latin America
- 8.5.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.5.2 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.5.3 Market size, by application, 2018 - 2032 (USD Million)
- 8.5.3.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.5.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.5.5 Brazil
- 8.5.5.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.5.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.5.5.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.5.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.5.6 Mexico
- 8.5.6.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.5.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.5.6.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.5.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.6 Middle East & Africa
- 8.6.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.6.2 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.6.3 Market size, by application, 2018 - 2032 (USD Million)
- 8.6.3.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.6.5 South Africa
- 8.6.5.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.6.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.6.5.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.6.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.6.6 Saudi Arabia
- 8.6.6.1 Market size, by raw material, 2018 - 2032 (USD Million)
- 8.6.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 8.6.6.2.1 Market size, by endovascular aneurysm repair, 2018 - 2032 (USD Million)
- 8.6.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
Chapter 9 Company Profiles
- 9.1 Becton, Dickinson & Company
- 9.1.1 Business overview
- 9.1.2 Financial data
- 9.1.3 Product landscape
- 9.1.4 Strategic outlook
- 9.1.5 SWOT analysis
- 9.2 B. Braun SE
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
- 9.3 Artivion, Inc.
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
- 9.4 Cook Medical
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
- 9.5 Medtronic
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
- 9.6 Terumo Corporation
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
- 9.7 Merit Medical
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
- 9.8 LeMaitre Vascular
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
- 9.9 Getinge AB
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
- 9.10 Endologix LLC.
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
- 9.11 Vascular Graft Solution
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
- 9.12 W.L Gore and Associates Inc
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis